epilation
Conditions
Interventions
Group A:The energy of using the testing instrument on one side is 3 levels (3.24 ± 0.65J/cm) 2), On the other side, a control device is used
Group B:The energy level of the experimental instrument used on one side is 5 levels (4.88 ± 0.98J/cm2), while the control instrument is used on the other side
Sponsors
West China Hospital, Sichuan University
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: [1] The age of the subjects is between 18 and 45 years old (including 18 and 45 years old); [2] Chinese women with good skin and mental health conditions; [3] Skin color meets Pantone color code P90 and below; [4] More than or equal to 30 hairs in the experimental area of armpits and calves; [5] Suitable skin area for hair removal (upper lip, armpits, and calves); [6] Voluntary participation in this clinical trial, understanding and willing to sign an informed consent form; [7] Willing to comply with all testing requirements.
Exclusion criteria
Exclusion criteria: [1] Pregnant, breastfeeding, or women of childbearing age who have not used medically effective contraceptive methods, or those who plan to conceive during the trial period; [2] Visually inspect the hair color of the test area to see if it is golden or light colored (such as white or transparent); [3] People with skin allergy or photosensitive constitution, or people who have recently taken photosensitive food, drugs (such as celery, isotretinoin, tetracycline and sulfa), or people who are allergic to water-soluble gel; [4] Any active implantable device implanted in the body (such as a pacemaker, neural stimulator, or insulin pump, etc.) [5] Previous diagnosis with a history of hypertension or heart disease; [6] Individuals with keloids or hypertrophic scars; Individuals with scar constitution; [7] Individuals with suspected skin tumor lesions; [8] Excessive exposure to sunlight, artificial tanning, or skin tone of brownish black or darker color within the first 4 weeks of treatment; [9] Within 6 months prior to the start of the study, individuals who have used any hair removal treatment, skin whitening products within 1 month, or cosmetics containing vitamin A at the test site; [10] History of malignant tumors, folliculitis, skin diseases, burned skin, and anticoagulant disorders, or other medications that affect hemostasis; [11] Have been exposed to direct sunlight or sunbathing within the three months prior to the start of the study; [12] Individuals with immunosuppressive diseases (including lupus erythematosus and Yellowia); [13] Individuals with infections, related skin diseases (such as herpes zoster), and hematomas in the experimental treatment area; [14] The skin in the treatment area has been treated with fruit acid (AHA), salicylic acid (BHA), topical isotretinoic acid, and rhododendron acid currently or within the past 2 weeks; [15] Individuals with any bleeding disorder (such as skin purpura); [16] Suffering from vascular diseases, such as varicose veins and vasodilation at the treatment site; [17] Individuals with photosensitive epilepsy; [18] Previously diagnosed with local or systemic skin infectious diseases or infectious diseases such as hepatitis and syphilis; [19] Open tearing or abrasion in the treatment area; [20] Individuals who are taking vasodilators, anti joint pain medications, aspirin, immunosuppressive agents, or taking isotretinoids; [21] Subjects who have participated in clinical trials or are currently participating in other clinical trials within the three months prior to the start of this study (excluding observational/non-interference studies); [22] Other situations that researchers believe are not suitable for enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| efficient; | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall improvement;Satisfaction;Pain level;Safety assessment; | — |
Countries
China
Contacts
Public ContactWang Xi
West China Hospital, Sichuan University
Outcome results
None listed